Keywords: BSO; Buthionine sulphoximine; DISC; Death-inducing signaling complex; DTNB; 5,5â²-dithiobis-(2-nitrobenzoic acid); DR5; Death receptor 5; FADD; Fas-Associated protein with Death Domain; FLIP; FADD-like IL-1β-converting enzyme-inhibitory protein; NAC; N-
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ABP1; auxin-binding protein 1; ACX; acyl CoA oxidase; ARF; auxin response factor; AUX1/LAX; auxin resistant 1/like AUX1; 2,4-D; 2,4-dichlorophenoxyacetic acid; DR5; D1-4 auxin-responsive promoter; GA; gibberellin; GUS; β-glucuronidase; IAA; indole-3-acet
Keywords: PBS; phosphate buffered saline; FBS; fetal bovine serum; DR5; death receptor 5; α-DR5; anti-DR5 agonist antibody; TNF; tumor necrosis factor; TNFR; TNF receptor; TRAIL; TNF-related apoptosis-inducing ligand; TM; transmembrane; MβCD; methyl-β-cyclodextr
Keywords: Adventitious root; CycB1; DR5; Lateral root; Root-on-a-plate assay; Solanum tuberosum;
Keywords: 8-OHdG; 8-oxo-2â²-deoxyguanosine; AMPK; AMP-activated protein kinase; ANT; adenine nucleotide translocator; Bad; Bcl2-associated agonist of cell death; BKA; bongkrekic acid; CAT; catalase; CsA; cyclosporine A; Cu/Zn-SOD; Cu/Zn-superoxide dismutase; DR4;
Keywords: Antioxidant; Oxidative stress; Redox; Tumor; Cancer therapy; Akt; protein kinase B; AMPK; 5â²-adenosine monophosphate-activated protein kinase; ATM; ataxia telangiectasia-mutated; DR5; death receptor 5; EC; epicatechin; ECG; epicatechin-3-gallate; EGC; e
Keywords: HCC; hepatocellular carcinoma; HBV; hepatitis B virus; HCV; hepatitis C virus; RT; radiotherapy; SHARP; a phase III study of Sorafenib in patients with advanced HCC; DR5; death receptor 5; TRAIL; tumour necrosis factor-related apoptosis-inducing ligand; D
Keywords: AIF; apoptosis-inducing factor; BSO; Buthionine sulfoximine; CAM; chorioallantoic membrane; cIAP; cellular inhibitor of apoptosis; DR5; death receptor-5; ENDOG; endonuclease G; ER; endoplasmatic reticulum; FCS; fetal calf serum; HBV; hepatitis B virus; HC
Keywords: Antibodies; Immunoconjugates; Immunotoxins; Ab; antibody; Ag; antigen; ADCC; antibody-dependent cell mediated cytotoxicity; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; AKT; protein kinase B; APC; antigen-presenting cell; Apo2L/TRAIL; t
Keywords: Aldh1a1; aldehyde dehydrogenase family 1 member A1; Bax; Bcl2-associated X protein; BNF; β-naphthoflavone; Col1a1; collagen, type I, alpha 1; Cox-2; cyclooxygenase 2; Cu; copper; Cxcl10; chemokine (C-X-C motif) ligand 10; Cx3cl1; chemokine (C-X3-C motif)
Bardoxolone methyl induces neuritogenesis in Neuro2a cells
Keywords: Akt; v-Akt Murine Thymoma Viral Oncogene; ARE; Antioxidant Responsive Element; BDNF; Brain Derived Neurotrophic Factor; CDDO; 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid; CHOP; C/EBP homologous protein; DR5; Death Receptor 5; ERK; Extracellular signal Re
Exosomes as a liquid biopsy for lung cancer
Keywords: Alix; ALG 2 interacting protein X; ALK; anaplastic lymphoma kinase; AREG; Amphiregulin; Atg2; autophagy related protein 2; AUC; area under the curve; BAL; bronchoalveolar lavage; circRNA; circular RNA; CSE; cigarette smoke extract; CTC; circulating tumor
Combination of novel DR5 targeting agonistic scFv antibody TR2-3 with cisplatin shows enhanced synergistic antitumor activity in vitro and in vivo
Keywords: DR5; death receptor 5; DR4; death receptor 4; TNF; tumor necrosis factor; TRAIL; TNF-related apoptosis inducing ligand; scFv; single chain fragment variable; MTT; methyl thazoy terazolium; IPTG; isopropyl β-D-1-thiogalactopyranoside; PBS; phosphate buffe
Antihypertensive drug-candesartan attenuates TRAIL resistance in human lung cancer via AMPK-mediated inhibition of autophagy flux
Keywords: Candesartan; Autophagy; TRAIL; Apoptosis; Lung cancer cells; DR5; AMPK;
Hepatitis B virus X protein and proinflammatory cytokines synergize to enhance TRAIL-induced apoptosis of renal tubular cells by upregulation of DR4
Keywords: Chip; chromatin immunoprecipitation; DR4; death receptor-4; DR5; death receptor-5; DLR; dual luciferase reporter; HBV; hepatitis B virus; HBx; hepatitis B virus X protein; HBV-GN; HBV-associated glomerulonephritis; IFN-γ; interferon gamma; NF-κB; nuclea
The unknown face of IRE1α - Beyond ER stress
Keywords: ER; endoplasmic reticulum; UPR; unfolded protein response; IRE1; inositol requiring kinase enzyme 1; XBP1; x-box binding protein 1; bZIP; basic leucine zipper domain; HAC1; histone acetyl transferase 1; ATF; activating transcription factor; RIDD; regulate
ER stress and cancer: The FOXO forkhead transcription factor link
Keywords: Endoplasmic reticulum; ER stress; Cancer; FOXO; Forkhead transcription factors; Unfolded protein response; AKT; Protein Kinase B; AKT1; Protein Kinase B Alpha; AMPK; AMP-activated protein kinase; ASK1; Apoptosis Signal Regulated Kinase 1; ATF4; Activating
Telmisartan generates ROS-dependent upregulation of death receptor 5 to sensitize TRAIL in lung cancer via inhibition of autophagy flux
Keywords: Telmisartan; Autophagy; ROS; TRAIL; DR5; Apoptosis;
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome
Keywords: IFN; interferon; ISGs; IFNstimulated genes; HCV; hepatitis C virus; IL-10; interleukin-10; PDL-1; programmed death-ligand 1; LCMV; lymphocytic choriomeningitis virus; IFNAR; IFNA receptor; IRFs; IFN regulatory factors; pDCs; plasmacytoid dendritic cells;
Overexpression of FADD and Caspase-8 inhibits proliferation and promotes apoptosis of human glioblastoma cells
Keywords: GBM; glioblastoma; NC; negative control; FADD; fas Associated protein with Death Domain; HRP; horse radish peroxidase; OD; optical density; FCM; flow cytometry; qRT-PCR; quantitative real-time polymerase chain reaction; SD; standard deviation; DR5; death
DATS sensitizes glioma cells to TRAIL-mediated apoptosis by up-regulation of death receptor 5 via ROS
Keywords: DATS; TRAIL; Apoptosis; ROS; p53; DR5; DATS; diallyl trisulfide; ROS; reactive oxygen species; NAC; N-acetyl-cysteine; PAGE; polyacrylamide gel electrophoresis; PARP; poly (ADP-ribose) polymerase; PBS; phosphate-buffered saline; SDS; sodium dodecyl sulfat
Research paperDevelopment of a bioassay as a measure of drozitumab-mediated apoptosis induced by soluble Fc gamma receptors
Keywords: Fc gamma receptors; Apoptosis; Drozitumab; Apo2L/TRAIL; DR5; Cross-linking;
Soluble Extracellular Domain of Death Receptor 5 Inhibits TRAIL-Induced Apoptosis by Disrupting Receptor-Receptor Interactions
Keywords: GFP; green fluorescent protein; CRD; cysteine-rich domain; CD; circular dichroism; DR5; long isoform of death receptor 5; DR5ÎCD; death receptor 5 without a cytoplasmic domain; DR5/M99A; death receptor 5 mutant methionine 99 to alanine; ECD; extracellula
Glutamine deprivation sensitizes human breast cancer MDA-MB-231 cells to TRIAL-mediated apoptosis
Keywords: Glutamine; TRAIL; Apoptosis; ER stress; CHOP; DR5;
Nanomedicine as a potent strategy in melanoma tumor microenvironment
Keywords: α-SMA; α-smooth muscle actin; MCP1; monocyte chemotactic protein 1; FAP; fibroblast activation protein; PDGF; platelet-derived growth factor; HGF; hepatocyte growth factor; CAPS; cancer associate protease; PLGA; poly (lactic-co-glycolic acid); ESMSVs; e
Melanoma-Directed Activation of Apoptosis Using a Bispecific Antibody Directed at MCSP and TRAIL Receptor-2/Death Receptor-5
Keywords: DR4; death receptor-4; DR5; death receptor-5; MCSP; melanoma-associated chondroitin sulfate proteoglycan; rhTRAIL; recombinant human soluble tumor necrosis factor-related apoptosis-inducing ligand; TRAIL; tumor necrosis factor-related apoptosis-inducing l
Research paperFerulic acid decreases cell viability and colony formation while inhibiting migration of MIA PaCa-2 human pancreatic cancer cells in vitro
Keywords: FA; Ferulic acid; CCND1; Cyclin D1; CDK4; Cyclin Dependent Kinase 4; CDK6; Cyclin Dependent Kinase 6; RB; Retinablastoma gene; BCL-XL; B-cell lymphoma-extra large; BID; BH3 Interacting Domain Death Agonist; DR4; HLA-DR4; DR5; Death receptor 5; FADD; Fas-A
Identification of a novel oxidative stress induced cell death by Sorafenib and oleanolic acid in human hepatocellular carcinoma cells
Keywords: CI; combination index; DR5; death receptor-5; ER; endoplasmatic reticulum; FCS; fetal calf serum; Fer-1; ferrostatin-1; FSC/SSC; forward/side scatter; HCC; hepatocellular carcinoma; IAP; Inhibitor of Apoptosis; MTT; inhibitor N-benzyloxycarbonyl-Val-Ala-A
The tetravalent anti-DR5 antibody without cross-linking direct induces apoptosis of cancer cells
Keywords: DR5; Apoptosis; Tetravalent; Antibody; Cancer cell
Liposome-bound TRAIL induces superior DR5 clustering and enhanced DISC recruitment in histiocytic lymphoma U937 cells
Keywords: TRAIL; Liposome; Leukemia; Caspase; DISC; DR5;
Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells
Keywords: Phosphorylated HSP27; Nonphosphorylated HSP27; Gemcitabine; Pancreatic cancer; TRAIL; tumor necrosis factor-related apoptosis-inducing ligand; DR5; death receptor 5; EGFP; enhanced green fluorescence protein; XIAP; X-linked inhibitor of apoptosis; MAPK; m
Sp1 transcription factor: A long-standing target in cancer chemotherapy
Keywords: Anticancer drugs; Prognosis; Sp1; Sp3; Transcription factors; Targeted therapy; AMPKα; AMP-activated protein kinase alpha catalytic subunit; Bcl-2; B cell/lymphoma 2; Bcl-w; member of the Bcl-2 family; Bid; BH3 interacting domain death agonist; CDK; cycl
Role of ATF3 in synergistic cancer cell killing by a combination of HDAC inhibitors and agonistic anti-DR5 antibody through ER stress in human colon cancer cells
Keywords: HDACI; ATF3; DR5; ER stress; Agonistic anti-DR5 antibody;
Ilimaquinone induces death receptor expression and sensitizes human colon cancer cells to TRAIL-induced apoptosis through activation of ROS-ERK/p38 MAPK-CHOP signaling pathways
Keywords: CHOP; CCAAT/enhancer-binding protein homologous protein; DR4, -5; death receptor 4, -5; ERK; extracellular signal-regulated kinase; p38 MAPK; p38 mitogen-activated protein kinase; JNK; c-Jun N-terminal kinase; PARP; poly-ADPribose polymerase; ROS; reactiv
Reduction of death receptor 5 expression and apoptosis of CD4Â + T cells from HIV controllers
Keywords: (HIC); HIV-1 infected controllers; (IFN-α); interferon alpha; (pDC); plasmacytoid dendritic cell; (TRAIL); TNF-related Apoptosis-Inducing Ligand; (DR5); Death Receptor 5; HIV infected controllers; DR5; TRAIL; Apoptosis; CD4 + T cell;
Two death-inducing human TRAIL receptors to target in cancer: Similar or distinct regulation and function?
Keywords: TRAIL; DR4; DR5; Receptor preference; Apoptosis
Verrucarin A sensitizes TRAIL-induced apoptosis via the upregulation of DR5 in an eIF2α/CHOP-dependent manner
Keywords: TRAIL; tumor necrosis factor-related apoptosis-inducing ligand; ER; endoplasmic reticulum; DR5; death receptor 5; VA; verrucarin A; CHOP; CCAAT/enhancer binding protein homologous protein; eIF2α; eukaryotic translation initiation factor 2α; ROS; reactiv
Relevance of signaling molecules for apoptosis induction on influenza A virus replication
Keywords: Akt; v-akt murine thymoma viral oncogene homolog 1; Apaf-1; apoptotic protease activating factor 1; Bax; Bcl-2-associated x protein; Bcl-2; B-cell lymphoma 2; BH; Bcl-2 homology; Caspases; cysteine-aspartic acid protease; DAP3; death-associated protein
Ursolic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis
Keywords: Prostate cancer; Ursolic acid; TRAIL; Apoptosis; DR5;
A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer
Keywords: NSCLC; DR5; Tigatuzumab; Chemotherapy; Efficacy; Lung; Phase II;
Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer
Keywords: CDDP; cisplatin-diamine-dichloro platinum; DETANONOate; diethylenetriamine NONOate; DR5; death receptor 5; EMSA; electrophoretic mobility shift assay; NO; nitric oxide; siRNA; small interfering RNA; TMA; tissue microarray; TRAIL; tumor necrosis factor (TN
Capsaicin sensitizes TRAIL-induced apoptosis through Sp1-mediated DR5 up-regulation: Involvement of Ca2+ influx
Keywords: Capsaicin; TRAIL; DR5; Sp1; Ca2+;
The endoplasmic reticulum stress response is involved in apoptosis induced by aloe-emodin in HK-2 cells
Keywords: AE; Aloe-emodin; ASK1; apoptosis signal-regulating kinase 1; ATF; activating transcription factor; CHAC1; cation transport regulator-like protein 1; CHOP; CAAT/enhancer-binding protein-homologous protein; DR5; death receptor 5; eIF2α; eukaryotic initiati
An RNA Aptamer That Binds Carcinoembryonic Antigen Inhibits Hepatic Metastasis of Colon Cancer Cells in Mice
Keywords: Colorectal Cancer; Diagnostic Agent; Apoptosis; CRC; CEA; carcinoembryonic antigen; DR5; death receptor 5; FBS; fetal bovine serum; PEG; polyethylene glycol; SEAP; secreted human alkaline phosphatase; SELEX; systematic evolution of ligands by exponential
p53-Independent up-regulation of a TRAIL receptor DR5 by proteasome inhibitors: A mechanism for proteasome inhibitor-enhanced TRAIL-induced apoptosis
Keywords: TRAIL; Glioma; p53; DR5; Proteasome inhibitor; Velcade; Bortezomib
Induction of ROS, p53, p21 in DEHP- and MEHP-exposed LNCaP cells-protection by selenium compounds
Keywords: CM-H2DCFA; 5-(and 6-) chloromethyl-2â²,7â²-dichlorodihydrofluorescein diacetate; DAB; 3,3â²-diaminobenzidine; DCF; 2â²,7â²-dichlorofluorescein; DEHP; di(2-ethylhexyl)phthalate; DR5; death receptor 5; FBS; fetal bovine serum; FCS; fetal calf serum; GP
Tumor Necrosis FactorâRelated ApoptosisâInducing Ligand (TRAIL) and Its Death Receptor (DR5) in Peyronie's Disease. A Biomolecular Study of Apoptosis Activation
Keywords: Peyronie's Disease; Peyronie's Plaque Healing; Apoptosis; TRAIL; DR5;
Death Receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells
Keywords: Pemetrexed; DR5; c-FLIP; Apoptosis; CHOP; TRAIL;
Research ArticleHIV infection increases HCV-induced hepatocyte apoptosis
Keywords: HCV-HIV coinfection; Apoptosis; TRAIL receptor; JFH-1; Japanese Fulminant Hepatitis 1; TRAIL; TNF-related apoptosis-inducing ligand; PARP; poly (ADP-ribose)polymerase; TGF-β1; transforming growth factor beta1; DR4; Death receptor 4; DR5; death receptor
Conatumumab (AMG 655) coated nanoparticles for targeted pro-apoptotic drug delivery
Keywords: DR5; c-FLIP; Nanoparticles; Cancer; Caspase pathway; Conatumumab